30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Charlie Wagner

Track

Insider profile

Currently holds a position at Vertex Pharmaceuticals Inc

Positions

Position Company Period
Chief Financial Officer, Executive Vice President Vertex Pharmaceuticals Inc April 10, 2019 -
Chief Financial Officer, Executive Vice President Bruker Corp July 1, 2012 - June 12, 2015
Independent Director Bruker Corp Aug. 2, 2010 - June 4, 2012
Chief Financial Officer, Executive Vice President - Finance and Administration Progress Software Corp Nov. 15, 2010 - March 28, 2012
Charlie Wagner's trades of Vertex Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-08 2026-01-06
PlS Planned sale
30,266 -32.7%
91.80
US$3,167,114 		30,266 -32.7% 91.80 US$3,167,114
2026-01-06 2026-01-06
PrS Proposed sale
71,429
393.59
US$2,389,985 		71,429 393.59 US$2,389,985
2025-12-05 2025-12-03
PlS Planned sale
66,919 +9.7%
231.20
US$311,946 		66,919 +9.7% 231.20 US$311,946
2025-12-05 2025-12-03
PlS Planned sale
7,000 -13.5%
451.00
US$3,157,000 		7,000 -13.5% 451.00 US$3,157,000
2025-12-03 2025-12-03
PrS Proposed sale
7,000
461.00
US$3,227,000 		7,000 461.00 US$3,227,000
2025-12-03 2025-12-03
PrS Proposed sale
7,000
451.00
US$3,157,000 		7,000 451.00 US$3,157,000
2025-03-12 2025-03-10
PlS Planned sale
3,298 -6.0%
500.00
US$1,649,000 		3,298 -6.0% 500.00 US$1,649,000
2025-03-10 2025-03-10
PrS Proposed sale
3,298
500.00
US$1,649,000 		3,298 500.00 US$1,649,000
2024-11-13 2024-11-11
PlS Planned sale
3,000 -6.4%
518.27
US$1,554,810 		3,000 -6.4% 518.27 US$1,554,810
2024-11-12 2024-11-11
PrS Proposed sale
3,000
518.27
US$1,554,810 		3,000 518.27 US$1,554,810
2024-06-05 2024-06-03
PlS Planned sale
3,250 -6.5%
460.00
US$1,495,000 		3,250 -6.5% 460.00 US$1,495,000
2024-06-03 2024-06-03
PrS Proposed sale
3,250
460.00
US$1,495,000 		3,250 460.00 US$1,495,000
2024-05-30 2024-05-28
PlS Planned sale
3,250 -6.1%
454.79
US$1,478,068 		3,250 -6.1% 454.79 US$1,478,068
2024-05-28 2024-05-28
PrS Proposed sale
3,250
454.79
US$1,478,068 		3,250 454.79 US$1,478,068
2024-01-04 2024-01-02
PlS Planned sale
3,000 -6.4%
405.00
US$1,215,000 		3,000 -6.4% 405.00 US$1,215,000
2024-01-02 2024-01-02
PrS Proposed sale
3,000
405.00
US$1,215,000 		3,000 405.00 US$1,215,000
2023-11-21 2023-11-20
PlS Planned sale
3,000 -6.0%
349.88
US$1,049,640 		3,000 -6.0% 349.88 US$1,049,640
2023-11-20 2023-11-20
PrS Proposed sale
3,000
349.88
US$1,049,640 		3,000 349.88 US$1,049,640
2023-03-28 2023-03-24
PlS Planned sale
1,768 -3.4%
305.38
US$539,912 		1,768 -3.4% 305.38 US$539,912
2023-03-24 2023-03-24
PrS Proposed sale
1,768
305.38
US$539,912 		1,768 305.38 US$539,912
2023-03-21 2023-03-17
PlS Planned sale
16 -0.0%
301.13
US$4,818 		16 -0.0% 301.13 US$4,818
2023-03-21 2023-03-17
PlS Planned sale
240 -0.5%
299.58
US$71,899 		240 -0.5% 299.58 US$71,899
2023-03-21 2023-03-17
PlS Planned sale
360 -0.7%
298.09
US$107,312 		360 -0.7% 298.09 US$107,312
2023-03-21 2023-03-17
PlS Planned sale
240 -0.5%
296.30
US$71,112 		240 -0.5% 296.30 US$71,112
2023-03-21 2023-03-17
PlS Planned sale
784 -1.5%
295.43
US$231,617 		784 -1.5% 295.43 US$231,617
2023-03-21 2023-03-17
PlS Planned sale
360 -0.7%
294.52
US$106,027 		360 -0.7% 294.52 US$106,027
2023-03-17 2023-03-17
PrS Proposed sale
2,000
300.17
US$600,340 		2,000 300.17 US$600,340
2023-03-14 2023-03-13
PlS Planned sale
62 -0.1%
296.77
US$18,400 		62 -0.1% 296.77 US$18,400
2023-03-14 2023-03-13
PlS Planned sale
292 -0.5%
295.89
US$86,400 		292 -0.5% 295.89 US$86,400
2023-03-14 2023-03-13
PlS Planned sale
715 -1.3%
294.52
US$210,582 		715 -1.3% 294.52 US$210,582
2023-03-14 2023-03-13
PlS Planned sale
1,153 -2.1%
293.35
US$338,233 		1,153 -2.1% 293.35 US$338,233
2023-03-14 2023-03-13
PlS Planned sale
420 -0.8%
292.41
US$122,812 		420 -0.8% 292.41 US$122,812
2023-03-14 2023-03-13
PlS Planned sale
24 -0.0%
288.31
US$6,919 		24 -0.0% 288.31 US$6,919
2023-03-13 2023-03-13
PrS Proposed sale
2,666
293.83
US$783,341 		2,666 293.83 US$783,341
2023-03-14 2023-03-10
PlS Planned sale
102 -0.2%
294.94
US$30,084 		102 -0.2% 294.94 US$30,084
2023-03-14 2023-03-10
PlS Planned sale
27 -0.0%
293.61
US$7,927 		27 -0.0% 293.61 US$7,927
2023-03-14 2023-03-10
PlS Planned sale
185 -0.3%
292.68
US$54,146 		185 -0.3% 292.68 US$54,146
2023-03-14 2023-03-10
PlS Planned sale
541 -1.0%
291.47
US$157,685 		541 -1.0% 291.47 US$157,685
2023-03-14 2023-03-10
PlS Planned sale
30 -0.1%
289.44
US$8,683 		30 -0.1% 289.44 US$8,683
2023-03-14 2023-03-10
PlS Planned sale
327 -0.6%
288.91
US$94,474 		327 -0.6% 288.91 US$94,474
2023-03-14 2023-03-10
PlS Planned sale
515 -0.9%
287.83
US$148,232 		515 -0.9% 287.83 US$148,232
2023-03-14 2023-03-10
PlS Planned sale
361 -0.6%
286.64
US$103,477 		361 -0.6% 286.64 US$103,477
2023-03-10 2023-03-10
PrS Proposed sale
2,088
289.61
US$604,709 		2,088 289.61 US$604,709
2022-05-04 2022-05-02
PlS Planned sale
3 -0.0%
264.37
US$793 		3 -0.0% 264.37 US$793
2022-05-04 2022-05-02
PlS Planned sale
32 -0.1%
262.06
US$8,386 		32 -0.1% 262.06 US$8,386